P2RX7 and hematopoietic and lymphoid system neoplasm: However, P2X7 knockdown [46] or antagonism [47] reduces leukaemia growth in mice, so the use of a P2X7 antagonist or inhibitory mAb may have a dual role in both preventing GVHD whilst reducing leukaemia in blood cancer patients following alloHSCT.